ONCT
Oncternal Therapeutics Inc
NASDAQ: ONCT · HEALTHCARE · BIOTECHNOLOGY
$0.53
+0.00% today
Updated 2026-04-30
Market cap
$1.56M
P/E ratio
—
P/S ratio
0.72x
EPS (TTM)
$-11.69
Dividend yield
—
52W range
$0 – $0
Volume
—
Oncternal Therapeutics Inc (ONCT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,757.00%
ROE
-149.90%
ROA
-76.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2004 | $1.87M | $-22.35M | 100.00% | -1,247.67% | -1,197.00% |
| 2005 | $3.78M | $-36.84M | 58.41% | -1,019.54% | -974.06% |
| 2006 | $7.50M | $-35.51M | 89.70% | -513.22% | -473.15% |
| 2007 | $7.13M | $-40.36M | 91.29% | -638.56% | -566.36% |
| 2008 | $13.53M | $-51.78M | 95.20% | -402.76% | -382.76% |
| 2009 | $14.73M | $-46.26M | 91.24% | -316.72% | -314.03% |
| 2010 | $60.61M | $15.29M | 98.73% | 22.98% | 25.23% |
| 2011 | $14.74M | $-33.29M | 92.84% | -228.59% | -225.89% |
| 2012 | — | $-27.07M | — | — | — |
| 2013 | — | $-42.11M | — | — | — |
| 2014 | — | $-39.41M | — | — | — |
| 2015 | — | $-18.70M | — | — | — |
| 2016 | $-2.51M | $-17.72M | 200.00% | 1,032.78% | 705.85% |
| 2017 | $1.67M | $-30.44M | -459.32% | -1,831.24% | -1,818.34% |
| 2018 | $2.52M | $-38.42M | 98.18% | -1,549.35% | -1,523.92% |
| 2019 | $2.42M | $-15.91M | -318.93% | -1,365.28% | -656.16% |
| 2020 | $3.38M | $-17.21M | 100.00% | -519.76% | -509.90% |
| 2021 | $4.32M | $-31.30M | 100.00% | -726.91% | -725.38% |
| 2022 | $1.49M | $-43.39M | 100.00% | -3,016.58% | -2,912.28% |
| 2023 | $785000.00 | $-39.48M | -3,690.19% | -5,313.89% | -5,029.17% |